Era of biosimilars in rheumatology: reshaping the healthcare environment

Compared with the original approved biological drug on which it is based, a biosimilar has highly similar physicochemical characteristics and biological activity, as well as equivalent efficacy and no clinically meaningful differences in safety and immunogenicity. Before they are approved, biosimila...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:RMD Open
Main Authors: Smolen, Josef S, Goncalves, Joao, Quinn, Mark, Benedetti, Fabrizio, Lee, Jake Yongkwon
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2019
Fag:
Rheumatoid Arthritis
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560670/
https://ncbi.nlm.nih.gov/pubmed/31245050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-000900
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker